, a bio/informatics shared resource is still "open for business" - Visit the CDS website


James Crowe
Faculty Member
Last active: 3/31/2020

  1. Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. Thornburg NJ, Nannemann DP, Blum DL, Belser JA, Tumpey TM, Deshpande S, Fritz GA, Sapparapu G, Krause JC, Lee JH, Ward AB, Lee DE, Li S, Winarski KL, Spiller BW, Meiler J, Crowe JE (2013) J Clin Invest 123(10): 4405-9
    › Primary publication · 23999429 (PubMed) · PMC3784541 (PubMed Central)
  2. Gold nanorod vaccine for respiratory syncytial virus. Stone JW, Thornburg NJ, Blum DL, Kuhn SJ, Wright DW, Crowe JE (2013) Nanotechnology 24(29): 295102
    › Primary publication · 23799651 (PubMed) · PMC3754908 (PubMed Central)
  3. Discovering naturally processed antigenic determinants that confer protective T cell immunity. Gilchuk P, Spencer CT, Conant SB, Hill T, Gray JJ, Niu X, Zheng M, Erickson JJ, Boyd KL, McAfee KJ, Oseroff C, Hadrup SR, Bennink JR, Hildebrand W, Edwards KM, Crowe JE, Williams JV, Buus S, Sette A, Schumacher TN, Link AJ, Joyce S (2013) J Clin Invest 123(5): 1976-87
    › Primary publication · 23543059 (PubMed) · PMC3635741 (PubMed Central)
  4. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Xu R, Krause JC, McBride R, Paulson JC, Crowe JE, Wilson IA (2013) Nat Struct Mol Biol 20(3): 363-70
    › Primary publication · 23396351 (PubMed) · PMC3594569 (PubMed Central)
  5. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon SI, Song L, Tussey L, Crowe JE, Ward AB, Wilson IA (2013) J Virol 87(22): 12471-80
    › Primary publication · 24027321 (PubMed) · PMC3807900 (PubMed Central)
  6. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE (2012) Exp Hematol 40(12): 974-982.e1
    › Primary publication · 22885125 (PubMed) · PMC3611587 (PubMed Central)
  7. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Wen X, Krause JC, Leser GP, Cox RG, Lamb RA, Williams JV, Crowe JE, Jardetzky TS (2012) Nat Struct Mol Biol 19(4): 461-3
    › Primary publication · 22388735 (PubMed) · PMC3546531 (PubMed Central)
  8. Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB. Thornburg NJ, Hayward SL, Crowe JE (2012) mBio 3(6)
    › Primary publication · 23249809 (PubMed) · PMC3529541 (PubMed Central)
  9. Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. Shaikh FY, Utley TJ, Craven RE, Rogers MC, Lapierre LA, Goldenring JR, Crowe JE (2012) PLoS One 7(7): e40826
    › Primary publication · 22808269 (PubMed) · PMC3396619 (PubMed Central)
  10. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M (2012) Blood 119(10): 2417-21
    › Primary publication · 22262764 (PubMed) · PMC3311262 (PubMed Central)